Heart Disease Clinical Trials in Denver

Showing 181-200 of 210 trials

Paracor Ventricular Support System (PVSS) for Patients With Heart Failure

NCT00291551

This is a limited safety and feasibility study to evaluate the PVSS Introducer and Paracor Ventricular Support System when used to treat patients with heart failure. The implant, which is loaded onto the delivery system, is placed over the epicardial surface of the right and left ventricles. No formal hypothesis testing will be performed; descriptive statistics will be used to summarize patient outcomes. The results of the study will be used to guide the design and sample size estimation of future studies.

Heart Failure, Congestive

Paracor Medical, Inc39 participantsStarted Jan 2005

Birmingham, Alabama, United States • Denver, Colorado, United States • Gainesville, Florida, United States +9 more locations

COMPLETEDPHASE38.4 miles

TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions

NCT00371709

TAXUS ATLAS is a global, multi-center, single-arm, non-inferiority trial comparing results from patients treated with the TAXUS Liberté stent to an historical TAXUS Express control. The control group is a case-matched, blended population of TAXUS Express patients from the TAXUS IV and TAXUS V de novo clinical trials. The objective of the study is to evaluate clinical outcomes of TAXUS Liberté-SR stent in de novo lesions and to assess the non-inferiority of TAXUS Liberté versus TAXUS Express. The TAXUS Liberté-SR stent is hypothesized to have comparable safety and efficacy to the TAXUS Express stent.

Coronary Artery Disease

Boston Scientific Corporation871 participantsStarted Aug 2004

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Beverly Hills, California, United States +59 more locations

Paracor Ventricular Support System (PVSS) for Patients With Heart Failure

TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions

Heart Disease Trials in Other Cities

OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

Physiological Response to Exercise: Sensor Evaluation at Specified Exertions

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)

The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices

The Epidemiology of Ventricular Assist Device-Related Infections

Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V

The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?

OVATIO CRT and SITUS OTW LV Lead Post Approval Study

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure

Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge

Other Conditions in Denver